First American Trust Fsb Lowers stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : First American Trust Fsb reduced its stake in Johnson & Johnson by 19.13% during the most recent quarter end. The investment management company now holds a total of 51,050 shares of Johnson & Johnson which is valued at $5,913,632 after selling 12,075 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on Jan 4, 2017.Johnson & Johnson makes up approximately 1.81% of First American Trust Fsb’s portfolio.

Other Hedge Funds, Including , First National Bank Of Mount Dora Trust Investment Services reduced its stake in JNJ by selling 447 shares or 0.99% in the most recent quarter. The Hedge Fund company now holds 44,571 shares of JNJ which is valued at $5,163,105. Johnson & Johnson makes up approx 3.03% of First National Bank Of Mount Dora Trust Investment Services’s portfolio.Sentinel Trust Co Lba reduced its stake in JNJ by selling 464 shares or 3.37% in the most recent quarter. The Hedge Fund company now holds 13,314 shares of JNJ which is valued at $1,542,294. Johnson & Johnson makes up approx 0.21% of Sentinel Trust Co Lba’s portfolio.Cacti Asset Management boosted its stake in JNJ in the latest quarter, The investment management firm added 4,875 additional shares and now holds a total of 269,286 shares of Johnson & Johnson which is valued at $31,194,090. Johnson & Johnson makes up approx 2.91% of Cacti Asset Management’s portfolio.Lau Associates boosted its stake in JNJ in the latest quarter, The investment management firm added 266 additional shares and now holds a total of 41,543 shares of Johnson & Johnson which is valued at $4,812,341. Johnson & Johnson makes up approx 4.83% of Lau Associates’s portfolio.Toth Financial Advisory Corp boosted its stake in JNJ in the latest quarter, The investment management firm added 306 additional shares and now holds a total of 55,562 shares of Johnson & Johnson which is valued at $6,436,302. Johnson & Johnson makes up approx 1.85% of Toth Financial Advisory Corp’s portfolio.

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Johnson & Johnson closed down -0.56 points or -0.48% at $116.3 with 52,21,381 shares getting traded on Friday. Post opening the session at $116.67, the shares hit an intraday low of $115.76 and an intraday high of $117 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Johnson & Johnson reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Oct 18, 2016. Analyst had a consensus of $1.66. The company had revenue of $17820.00 million for the quarter, compared to analysts expectations of $17744.90 million. The company’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.49 EPS.

For any feedback and suggestions contact author at Susan.Hanchard@thefoundersdaily.com

Add Comment